Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
0.7251
+0.0047 (0.65%)
At close: Jul 21, 2026, 4:00 PM EDT
0.7251
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Definitive Healthcare stock has a consensus rating of "Hold" and an average price target of $2.20. The average 1-year stock price forecast is 203.41% higher than the current stock price, while the lowest is $0.70 (-3.46%) and the highest is $3.00 (+313.74%).
Price Target: $2.20 (+203.41%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 6 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 10 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Downgrades $3.5 → $0.7 | Sell | Downgrades | $3.5 → $0.7 | -3.46% | Jun 29, 2026 |
| Barclays | Barclays | Sell Reiterates $1 | Sell | Reiterates | $1 | +37.91% | Jun 16, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $1.3 → $1.1 | Hold | Maintains | $1.3 → $1.1 | +51.70% | May 8, 2026 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 8, 2026 |
Financial Forecast
Revenue This Year
223.44M
from 241.52M
Decreased by -7.49%
Revenue Next Year
222.16M
from 223.44M
Decreased by -0.57%
EPS This Year
0.18
from 0.24
Decreased by -23.23%
EPS Next Year
0.18
from 0.18
Decreased by -1.70%
EPS and Forward PE are based on non-GAAP adjusted numbers.